TENX

Tenax Therapeutics Inc.

Price

$1.90

return (12m)

-68.44%

p/e

-1.44

p/bv

0.82

DIVIDEND YIELD

0.00%

TENX price

Tenax Therapeutics

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment TENX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-87.78%

3 months

-84.63%

1 year

-68.44%

2 years

-55.29%

5 years

-99.92%

10 years

-100.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals TENX

Valuation

P/E

-1.44

Sector -4.38

Industry -4.38

P/BV

0.82

Sector 2.02

Industry 2.02

P/Revenue (PSR)

Sector -4.40

Industry -4.40

EV/EBITDA

1.30

Sector -263.09

Industry -263.09

EV/EBIT

1.30

Sector -702.90

Industry -702.90

P/EBITDA

-1.40

Sector -4.39

Industry -4.39

P/EBIT

-1.40

Sector -4.73

Industry -4.73

P/Total Assets

0.77

Sector 1.49

Industry 1.49

P/Net Current Assets

0.82

Sector -11.70

Industry -11.70

P/Working Capital

0.82

Sector -3.19

Industry -3.19

EPS

-1.27

Sector -2.14

Industry -2.14

BVPS

2.23

Sector 1.85

Industry 1.85

Efficiency

Gross Margin

0.00%

Sector 36.74%

Industry 36.74%

EBITDA Margin

Sector -16,244.81%

Industry -16,244.81%

EBIT Margin

Sector -4,202,541.34%

Industry -4,202,541.34%

Operating Margin

0.00%

Sector -38.22%

Industry -38.22%

Net Profit Margins

0.00%

Sector -39.69%

Industry -39.69%

Asset Turnover

0.00

Sector 0.03

Industry 0.03

Profitability

ROE

-57.10%

Sector -65.14%

Industry -65.14%

ROA

-53.31%

Sector -65.53%

Industry -65.53%

ROIC

-10,264.48%

Sector -2,103.35%

Industry -2,103.35%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

15.08

Sector 2.90

Industry 2.90

Net Debt / EBITDA

6.28

Sector -6.07

Industry -6.07

Net Debt / EBIT

6.28

Sector -8.26

Industry -8.26

Net Debt / Equity

-1.04

Sector -1.07

Industry -1.07

Gross Debt / Equity

0.00

Sector -0.05

Industry -0.05

Equity/Assets

0.93

Sector 0.41

Industry 0.41

Liabilities/Assets

0.07

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

14.83%

Sector -

Industry -

Fundamentals TENX

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
TENX Tenax Therapeutics Inc.	$1.90	-68.39%	0.00%	-1.44	0.82	-57.10%	0.00%
JNJ Johnson & Johnson	$273.41	58.46%	2.02%	29.66	7.34	24.76%	21.48%
PFE Pfizer Inc.	$28.24	21.45%	6.54%	34.62	1.75	5.07%	6.80%
ABBV AbbVie Inc.	$265.97	33.11%	2.73%	70.02	-74.53	-106.44%	9.81%
NVO Novo Nordisk A/S	$46.48	-9.14%	4.09%	11.13	5.91	53.11%	35.32%
MRK Merck & Co. Inc.	$152.20	87.95%	2.45%	106.68	8.06	7.56%	4.77%
AZN AstraZeneca PLC	$164.95	4.92%	2.07%	22.98	4.77	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$67.61	46.95%	3.93%	14.06	5.85	41.59%	18.87%
ZTS Zoetis Inc.	$76.68	-48.52%	2.77%	11.89	9.88	83.10%	27.49%
REGN Regeneron Pharmaceuticals Inc.	$840.84	43.05%	0.45%	19.09	2.61	13.65%	27.86%
AMGN Amgen Inc.	$442.36	55.11%	2.39%	25.30	18.93	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$107.62	56.06%	0.00%	27.82	80.17	288.14%	24.86%
MCK McKesson Corporation	$853.71	27.85%	0.38%	22.42	-79.15	-352.96%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$552.06	41.60%	0.00%	29.26	6.36	21.76%	35.00%
CAH Cardinal Health Inc.	$234.85	58.85%	0.88%	31.61	-19.89	-62.92%	0.67%
HRMY Harmony Biosciences Holdings Inc.	$39.93	9.67%	0.00%	12.18	2.21	18.14%	18.89%
BIIB Biogen Inc.	$221.56	63.02%	0.00%	37.04	1.64	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

TENX Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Tenax Therapeutics

Tenax Therapeutics Inc.

Average Investor10 user rating

4.0 (1 people)

United States

59 years

Founded: 1967

1997

Time since IPO - 29 years

10

Employees

Tenax Therapeutics Inc. (United States) is listed on the Nasdaq and has a market capitalization of $93.59 million, with shareholders equity totaling $113.59 million.

The company employs approximately 10 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Tenax Therapeutics Inc. reported $- in revenue, generating net income of $-64.86 million.

Key financial metrics include a P/E ratio of -1.44, a price-to-book (P/B) ratio of 0.82, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker TENX.

Market cap

$93.59 million

Net worth

$113.59 million

$113,590,000.00

Assets

$121.66 million

$121,660,000.00

Total Shares Outstanding

51.00 million

51,000,000

Average Daily Trading Volume

$3.83 million

$3,833,732.00

Sector

Health Care

Industry

Biotechnology

TENX

TENX revenue and profits

Financial Results TENX

DRAG THE FRAME TO SEE MORE DATA

TENX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$853.71 22,07% (12M)

P/E

22.42

0.38%

ROE

-352.96%

P/BV

-79.15

CAH - Cardinal Health

$234.85 55,51% (12M)

P/E

31.61

0.88%

ROE

-62.92%

P/BV

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12M)

P/E

29.66

2.02%

ROE

24.76%

P/BV

7.34

ABBV - AbbVie

$265.97 31,23% (12M)

P/E

70.02

2.73%

ROE

-106.44%

P/BV

-74.53

MRK - Merck & Co.

$152.20 86,97% (12M)

P/E

106.68

2.45%

ROE

7.56%

P/BV

8.06

AZN - AstraZeneca

$164.95 5,00% (12M)

P/E

22.98

2.07%

ROE

20.74%

P/BV

4.77

PFE - Pfizer

$28.24 21,16% (12M)

P/E

34.62

6.54%

ROE

5.07%

P/BV

1.75

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$853.71 22,07% (12 M)

P/L

22.42

0.38%

ROE

-352.96%

P/VP

-79.15

CAH - Cardinal Health

$234.85 55,51% (12 M)

P/L

31.61

0.88%

ROE

-62.92%

P/VP

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12 M)

P/L

29.66

2.02%

ROE

24.76%

P/VP

7.34

ABBV - AbbVie

$265.97 31,23% (12 M)

P/L

70.02

2.73%

ROE

-106.44%

P/VP

-74.53

MRK - Merck & Co.

$152.20 86,97% (12 M)

P/L

106.68

2.45%

ROE

7.56%

P/VP

8.06

AZN - AstraZeneca

$164.95 5,00% (12 M)

P/L

22.98

2.07%

ROE

20.74%

P/VP

4.77

PFE - Pfizer

$28.24 21,16% (12 M)

P/L

34.62

6.54%

ROE

5.07%

P/VP

1.75

Frequently Asked Questions

What is the price of Tenax Therapeutics (TENX) today?

A cotação de Tenax Therapeutics (TENX) hoje está em US$ 1.90, com uma variação de -68.44% em relação ao último ano. A cotação de Tenax Therapeutics (TENX) iniciou o ano negociando na casa dos US$ 12.19 e hoje está em US$ 1.90. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Tenax Therapeutics (TENX) e dados de ações do Ibovespa e mercados internacionais.

Quando Tenax Therapeutics (TENX) paga dividendos?

Tenax Therapeutics (TENX) não distribuiu dividendos no último ano.

Is Tenax Therapeutics (TENX) a good investment?

Atualmente, Tenax Therapeutics (TENX) está cotada a US$ 1.90, com um P/L de -1.44, representando um desvio de -238% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de -68.44 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de -68.44%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Tenax Therapeutics (TENX) stock?

Investir em ações de Tenax Therapeutics (TENX) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Tenax Therapeutics (TENX) yield today?

A rentabilidade de Tenax Therapeutics (TENX) foi de -87.78% no último mês, -68.44% no último ano e -99.92% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Tenax Therapeutics (TENX) hoje, o investimento total seria de US$ 190.00, com base na cotação atual de US$ 1.90.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 59.96
Em 5 anos: US$ 0.15
Em 10 anos: US$ 0.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

TENX

Tenax Therapeutics Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment TENX

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING TENX WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Tenax Therapeutics

Tenax Therapeutics Inc.

United States

59 years

1997

10

PROFIT X PRICE TENX

Financial Results TENX

TENX cash flow

Asset, Revenue and Profit Growth - TENX

TENX balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions